HUMAN METABOLOME TECHNOLOGIES INCHUMAN METABOLOME TECHNOLOGIES INCHUMAN METABOLOME TECHNOLOGIES INC

HUMAN METABOLOME TECHNOLOGIES INC

No trades
See on Supercharts

6090 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Human Metabolome Technologies, Inc. engages in the business of diagnostic technology and medical products. Its operations are carried out through the following segments: Metabolome Analysis, Biomarker, and Temporary Staffing. The Metabolome Analysis segment provides contract analysis service based on the metabolome analysis on measured samples from the clients. The Biomarker segment deals with the development of biomarker license in collaboration with the group companies. The Temporary Staffing segment provides researchers and technicians. The company was founded by Yoshihiro Otaki, Masaru Tomita, and Tomoyoshi Soga on July 1, 2003 and is headquartered in Tsuruoka, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

6090 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company